Damarla Lab

Johns Hopkins University

INTERNAL MEDICINE/MEDICINE

Baltimore · United States

NIH-funded
Rate this labNo reviews yet — be the first.

Research focus

NIH R01 · 2024

Targeting Divergent Roles of Caspase 3 to Promote Endothelial Barrier Recovery

PROJECT SUMMARY Acute Respiratory Distress Syndrome (ARDS) is a devastating illness with an annual incidence of 200,000 and a mortality of 40%. Endothelial barrier dysfunction is critical for the pathogenesis of vascular permeability and the resulting tissue edema and profound hypoxia seen in ARDS. Endothelial barrier dysfunction in ARDS is a complex phenomenon involving cytoskeletal changes in response to pro-inflammatory mediators, which can also precipitate endothelial cell apoptosis, a programmed form of cell death. While cytoskeletal changes are reversible and are eventually followed by recovery of the endothelial barrier, endothelial cell apoptosis represents a final cellular fate and…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.

Reviews

← All labs at Johns Hopkins University